This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Ucb Pharma Gmbh. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Didier Bouvy
Introduction
Didier Bouvy is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of amino acid derivatives. With a total of 2 patents to his name, Bouvy's work has implications for the treatment of various medical conditions.
Latest Patents
Bouvy's latest patents focus on processes for the preparation of amino acid derivatives. The first patent describes a method for manufacturing compounds of formula (B) through the hydrogenation of compounds of general formula (A). This process is particularly relevant for the production of Lacosamide (LCM), a compound that serves as an anticonvulsive drug. The second patent presents an alternative process for the preparation of amino derivatives, emphasizing an improved method for manufacturing optically enriched (R)-2-acetamido-N-benzyl-3-methoxypropion-amide. This compound is also recognized for its utility in anticonvulsive treatments.
Career Highlights
Didier Bouvy is associated with UCB Pharma GmbH, a company known for its focus on innovative pharmaceuticals. His work at UCB Pharma has allowed him to explore and develop new processes that enhance the efficacy of drug manufacturing.
Collaborations
Bouvy has collaborated with notable colleagues such as Alain Merschaert and David Vasselin. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Didier Bouvy stands out as an influential inventor in the pharmaceutical industry, with a focus on amino acid derivatives that have significant medical applications. His contributions continue to impact the field positively.